FH-deficient uterine leiomyomas tumors undergo the impairment of oxidative phosphorylation and metabolic shift to aerobic glycolysis and the increase of HIF-1α, contributing to the oncogenic growth of FH-deficient cells [28,29]. The gene discussed is HIF1A; the disease is uterine corpus leiomyoma.